Itraconazol Actavis

Itraconazole, the active ingredient in Itraconazol Actavis, is a azole antifungal presented as an oral capsule for oral use. It treats systemic and superficial fungal infections in adults and children as prescribed.

GNH USA supplies Itraconazol Actavis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Itraconazole is an azole antifungal that acts on a broad range of fungal pathogens, making it suitable for several clinical indications. - Dermatophytosis: resolves skin infections caused by dermatophyte fungi. - Onychomycosis: eradicates fungal infection of the nails. - Systemic mycoses (e.g., aspergillosis, blastomycosis, histoplasmosis): treats deep‑seated fungal diseases. - Candida infections: clears invasive or mucosal candidiasis.

Adverse reactions may occur with itraconazole therapy.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Abdominal pain: cramping or discomfort in the abdomen. - Rash: skin redness or itching. - Taste disturbance: altered or reduced taste perception. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac failure: worsening of heart failure symptoms. - Visual disturbances: blurred vision or photopsia. - Severe allergic reactions: anaphylaxis or angioedema. - Acute pancreatitis: sudden abdominal pain with elevated enzymes.

Before initiating therapy, clinicians should consider several safety measures. - Liver function monitoring: assess baseline enzymes and repeat during treatment. - Drug interaction review: avoid concomitant strong CYP3A4 inhibitors. - Cardiac assessment: use cautiously in patients with existing heart failure. - Pregnancy risk: avoid use unless benefits outweigh potential risks. - Hypersensitivity: discontinue if allergic reaction occurs. - Store at below 25°C: keep in the original pack, protect from moisture.

Itraconazole has a notable potential for drug‑drug interactions that require careful management.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may cause toxic itraconazole levels. - Certain statins (e.g., simvastatin): increased risk of myopathy. - Anti‑arrhythmics (e.g., quinidine): may lead to cardiac conduction abnormalities.

Moderate Interactions (Monitor Closely): - Rifampin and other CYP3A4 inducers: may reduce itraconazole efficacy. - Oral contraceptives: may decrease contraceptive effectiveness.